company background image
HAEK logo

HAEMATO XTRA:HAEK Stock Report

Last Price

€21.40

Market Cap

€111.9m

7D

0%

1Y

16.3%

Updated

28 Mar, 2024

Data

Company Financials +

HAEMATO AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for HAEMATO
Historical stock prices
Current Share Price€21.40
52 Week High€28.00
52 Week Low€17.40
Beta1.3
1 Month Change0.94%
3 Month Change-23.02%
1 Year Change16.30%
3 Year Change-34.95%
5 Year Change-56.94%
Change since IPO-47.80%

Recent News & Updates

What Is HAEMATO AG's (ETR:HAEK) Share Price Doing?

Feb 22
What Is HAEMATO AG's (ETR:HAEK) Share Price Doing?

Potential Upside For HAEMATO AG (ETR:HAEK) Not Without Risk

Jan 04
Potential Upside For HAEMATO AG (ETR:HAEK) Not Without Risk

The Returns At HAEMATO (ETR:HAEK) Aren't Growing

Sep 12
The Returns At HAEMATO (ETR:HAEK) Aren't Growing

Recent updates

What Is HAEMATO AG's (ETR:HAEK) Share Price Doing?

Feb 22
What Is HAEMATO AG's (ETR:HAEK) Share Price Doing?

Potential Upside For HAEMATO AG (ETR:HAEK) Not Without Risk

Jan 04
Potential Upside For HAEMATO AG (ETR:HAEK) Not Without Risk

The Returns At HAEMATO (ETR:HAEK) Aren't Growing

Sep 12
The Returns At HAEMATO (ETR:HAEK) Aren't Growing

HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20

May 20
HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20

We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)

May 12
We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)

HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher

Dec 08
HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher

The Strong Earnings Posted By HAEMATO (ETR:HAEK) Are A Good Indication Of The Strength Of The Business

May 24
The Strong Earnings Posted By HAEMATO (ETR:HAEK) Are A Good Indication Of The Strength Of The Business

HAEMATO (ETR:HAEK) Hasn't Managed To Accelerate Its Returns

Nov 17
HAEMATO (ETR:HAEK) Hasn't Managed To Accelerate Its Returns

HAEMATO (ETR:HAEK) Will Be Hoping To Turn Its Returns On Capital Around

May 30
HAEMATO (ETR:HAEK) Will Be Hoping To Turn Its Returns On Capital Around

We're Not Very Worried About HAEMATO's (ETR:HAEK) Cash Burn Rate

Mar 08
We're Not Very Worried About HAEMATO's (ETR:HAEK) Cash Burn Rate

What Do The Returns At HAEMATO (ETR:HAEK) Mean Going Forward?

Feb 15
What Do The Returns At HAEMATO (ETR:HAEK) Mean Going Forward?

Estimating The Fair Value Of HAEMATO AG (ETR:HAEK)

Jan 25
Estimating The Fair Value Of HAEMATO AG (ETR:HAEK)

Is Now An Opportune Moment To Examine HAEMATO AG (ETR:HAEK)?

Jan 04
Is Now An Opportune Moment To Examine HAEMATO AG (ETR:HAEK)?

Reflecting on HAEMATO's (ETR:HAEK) Share Price Returns Over The Last Three Years

Dec 14
Reflecting on HAEMATO's (ETR:HAEK) Share Price Returns Over The Last Three Years

Shareholder Returns

HAEKDE HealthcareDE Market
7D0%-0.5%2.5%
1Y16.3%-0.4%7.0%

Return vs Industry: HAEK exceeded the German Healthcare industry which returned -0.4% over the past year.

Return vs Market: HAEK exceeded the German Market which returned 7% over the past year.

Price Volatility

Is HAEK's price volatile compared to industry and market?
HAEK volatility
HAEK Average Weekly Movement5.7%
Healthcare Industry Average Movement5.3%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: HAEK's share price has been volatile over the past 3 months.

Volatility Over Time: HAEK's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199376Patrick Brenskehttps://www.haemato.ag

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements.

HAEMATO AG Fundamentals Summary

How do HAEMATO's earnings and revenue compare to its market cap?
HAEK fundamental statistics
Market cap€111.87m
Earnings (TTM)€9.61m
Revenue (TTM)€260.81m

11.6x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HAEK income statement (TTM)
Revenue€260.81m
Cost of Revenue€241.08m
Gross Profit€19.73m
Other Expenses€10.12m
Earnings€9.61m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.84
Gross Margin7.56%
Net Profit Margin3.68%
Debt/Equity Ratio0.2%

How did HAEK perform over the long term?

See historical performance and comparison

Dividends

5.6%

Current Dividend Yield

64%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.